Market Tracker

01/30 6:05pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

36.67
Data as of Jan 30
 -1.02 / -2.71%
Today’s Change
21.34
Today|||52-Week Range
39.49
+15.75%
Year-to-Date

Today’s Trading

Previous close37.69
Today’s open37.35
Day’s range36.25 - 37.38
Volume798,705
Average volume (3 months)670,268
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+56.24%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)-12.07%
P/E ratio24.9
Price/Sales3.29
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp+0.07+1.11%
NBIXNeurocrine Bioscienc...-0.69-2.01%
--Cosmo Pharmaceutical...-11.95-6.38%
MYGNMyriad Genetics Inc-0.92-2.40%
Data as of 4:14pm ET, 01/30/2015

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$0.12
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts